Fingerprint
Dive into the research topics of 'Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment
David S. Siegel, Gary J. Schiller, Christy Samaras, Michael Sebag, Jesus Berdeja, Siddhartha Ganguly, Jeffrey Matous, Kevin Song, Christopher S. Seet, Giampaolo Talamo, Mirelis Acosta-Rivera, Michael Bar, Donald Quick, Bertrand Anz, Gustavo Fonseca, Donna Reece, William E. Pierceall, Weiyuan Chung, Faiza Zafar, Amit Agarwal
Research output: Contribution to journal › Article › peer-review
37
Scopus
citations